IN8bio (INAB) Short Interest Ratio & Short Volume $2.26 +0.02 (+0.89%) Closing price 04:00 PM EasternExtended Trading$2.26 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IN8bio Short Interest DataIN8bio (INAB) has a short interest of 110,200 shares, representing 2.85% of the float (the number of shares available for trading by the public). This marks a -23.21% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 165,133 shares to cover all short positions.Current Short Interest110,200 sharesPrevious Short Interest143,500 sharesChange Vs. Previous Month-23.21%Dollar Volume Sold Short$234.73 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares4,540,000 sharesFloat Size3,860,000 sharesShort Percent of Float2.85%Today's Trading Volume44,585 sharesAverage Trading Volume165,133 sharesToday's Volume Vs. Average27% Short Selling IN8bio? Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINAB Short Interest Over TimeINAB Days to Cover Over TimeINAB Percentage of Float Shorted Over Time IN8bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025110,200 shares $234.73 thousand -23.2%2.9%0.5 $2.13 7/15/2025143,500 shares $309.96 thousand -37.3%4.9%0.7 $2.16 6/30/2025229,000 shares $478.61 thousand -5.9%7.8%1.3 $2.09 6/15/2025243,300 shares $549.86 thousand +142.1%9.0%1.5 $2.26 5/31/2025100,500 shares $444.41 thousand -91.9%3.7%0.7 $4.42 5/15/20251,240,000 shares $164.30 thousand +190.9%1.7%0.9 $0.13 4/30/2025426,300 shares $72.04 thousand -10.9%0.6%0.1 $0.17 4/15/2025478,300 shares $78.06 thousand -52.6%0.7%0.1 $0.16 3/31/20251,010,000 shares $167.66 thousand -39.5%1.6%0.2 $0.17 3/15/20251,670,000 shares $376.42 thousand +108.6%2.6%0.3 $0.23 Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025800,500 shares $215.41 thousand -78.7%1.2%0.2 $0.27 2/15/20253,760,000 shares $1.09 million +768.0%6.5%0.8 $0.29 1/31/2025433,200 shares $110.81 thousand -51.9%0.8%0.1 $0.26 1/15/2025899,800 shares $272.64 thousand +86.1%1.6%1 $0.30 12/31/2024483,600 shares $124.38 thousand -49.8%0.8%0.4 $0.26 12/15/2024963,800 shares $274.49 thousand +12.2%1.7%0.8 $0.28 11/30/2024859,300 shares $261.83 thousand -35.9%1.7%0.7 $0.30 11/15/20241,340,000 shares $449.30 thousand +34.0%2.7%1.2 $0.34 10/31/20241,000,000 shares $280.20 thousand +578.4%3.1%0.9 $0.28 10/15/2024147,400 shares $34.49 thousand -16.5%0.5%0.2 $0.23 9/30/2024176,500 shares $47.66 thousand -6.6%0.5%0.7 $0.27 9/15/2024188,900 shares $59.79 thousand -4.5%0.6%0.8 $0.32 8/31/2024197,800 shares $104.12 thousand -28.9%0.6%0.5 $0.53 8/15/2024278,200 shares $167.73 thousand +13.6%0.9%0.7 $0.60 7/31/2024244,900 shares $205.69 thousand -46.5%0.8%0.7 $0.84 7/15/2024457,800 shares $388.67 thousand -39.5%1.5%1.2 $0.85 6/30/2024756,900 shares $640.72 thousand +94.2%2.5%1.4 $0.85 6/15/2024389,700 shares $424.77 thousand +489.6%1.3%0.7 $1.09 5/31/202466,100 shares $78.66 thousand -37.4%0.2%0.2 $1.19 5/15/2024105,500 shares $119.22 thousand -41.4%0.4%0.3 $1.13 4/30/2024179,900 shares $183.50 thousand -64.9%0.6%0.5 $1.02 4/15/2024512,000 shares $522.24 thousand +892.3%1.8%1.5 $1.02 3/31/202451,600 shares $60.89 thousand -39.2%0.2%0.3 $1.18 3/15/202484,800 shares $96.67 thousand +296.3%0.3%0.5 $1.14 2/29/202421,400 shares $23.75 thousand -47.9%0.1%0 $1.11 2/15/202441,100 shares $45.21 thousand -68.1%0.1%0.1 $1.10 1/31/2024129,000 shares $167.70 thousand +49.1%0.5%0.2 $1.30 1/15/202486,500 shares $131.48 thousand -25.5%0.4%0.1 $1.52 12/31/2023116,100 shares $160.22 thousand -77.9%0.7%0.2 $1.38 12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91Gold Hit $3,500. Here’s What’s Next… (Ad)Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldman Sachs and JPMorgan forecasting as high as $6,000, now may be the most critical time in a generation to move.Claim Your Copy Before Prices Surge Again 11/30/202389,000 shares $73.87 thousand +222.5%0.4%0.6 $0.83 11/15/202327,600 shares $25.93 thousand -51.0%0.1%0.3 $0.94 10/31/202356,300 shares $55.17 thousand -0.2%0.3%0.7 $0.98 10/15/202356,400 shares $52.72 thousand -43.1%0.3%0.5 $0.93 9/30/202399,100 shares $103.06 thousand +166.4%0.5%0.8 $1.04 9/15/202337,200 shares $34.22 thousand -57.4%0.2%0.3 $0.92 8/31/202387,300 shares $91.67 thousand +90.2%0.4%0.5 $1.05 8/15/202345,900 shares $54.62 thousand +81.4%0.2%0.2 $1.19 7/31/202325,300 shares $29.85 thousand -70.1%0.1%0.1 $1.18 7/15/202384,700 shares $137.21 thousand +22.2%0.6%0 $1.62 6/30/202369,300 shares $106.72 thousand -21.9%0.5%0 $1.54 6/15/202388,700 shares $188.04 thousand +14.8%0.6%0 $2.12 5/31/202377,300 shares $234.99 thousand -43.8%0.6%0 $3.04 5/15/2023137,500 shares $338.25 thousand -88.5%1.1%0 $2.46 4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46 4/15/2023145,000 shares $175.45 thousand -3.0%1.7%0.1 $1.21 3/31/2023149,500 shares $194.35 thousand -9.4%1.7%1.9 $1.30 3/15/2023165,000 shares $219.45 thousand -20.6%1.9%1.8 $1.33 2/28/2023207,800 shares $317.93 thousand +127.4%2.4%2.2 $1.53 2/15/202391,400 shares $182.80 thousand -13.7%1.1%1 $2.00 1/31/2023105,900 shares $243.15 thousand -10.3%1.2%1.7 $2.30 1/15/2023118,000 shares $272.58 thousand -10.4%1.4%1.9 $2.31 12/30/2022131,700 shares $304.23 thousand +28.5%1.5%2 $2.31 12/15/2022102,500 shares $187.58 thousand +45.8%1.2%1.7 $1.83 11/30/202270,300 shares $122.32 thousand +42.9%0.8%1.1 $1.74 11/15/202249,200 shares $77.74 thousand +21.8%0.6%0 $1.58 10/31/202240,400 shares $78.78 thousand -9.0%0.5%0 $1.95 10/15/202244,400 shares $89.24 thousand -13.3%0.5%0 $2.01 9/30/202251,200 shares $103.42 thousand -40.5%0.6%0 $2.02 9/15/202286,100 shares $237.64 thousand +154.7%1.0%0.1 $2.76 8/31/202233,800 shares $87.54 thousand -17.2%0.8%0 $2.59 8/15/202240,800 shares $77.11 thousand +206.8%0.9%0.7 $1.89 7/31/202213,300 shares $33.78 thousand +44.6%0.1%1.1 $2.54 7/15/20229,200 shares $19.96 thousand -8.9%0.1%0.7 $2.17 6/30/202210,100 shares $22.83 thousand -24.6%0.1%0.6 $2.26 6/15/202213,400 shares $28.54 thousand -21.2%0.1%0.5 $2.13 5/31/202217,000 shares $37.57 thousand +28.8%0.1%0.5 $2.21 5/15/202213,200 shares $36.70 thousand +2.3%0.1%0.3 $2.78 4/30/202212,900 shares $30.96 thousand -45.6%0.1%0.3 $2.40 4/15/202223,700 shares $82.48 thousand +68.1%0.2%0.5 $3.48 3/31/202214,100 shares $46.95 thousand +18.5%0.1%0.3 $3.33 3/15/202211,900 shares $35.70 thousand -55.4%0.1%0.3 $3.00 2/28/202226,700 shares $112.14 thousand -62.3%0.2%0.8 $4.20 2/15/202270,900 shares $303.45 thousand +6.5%0.6%2 $4.28 1/31/202266,600 shares $224.44 thousand +17.3%0.5%1.8 $3.37 1/15/202256,800 shares $230.04 thousand +108.8%N/A1.9 $4.05 12/31/202127,200 shares $119.41 thousand No Change0.2%0.9 $4.39 INAB Short Interest - Frequently Asked Questions What is IN8bio's current short interest? Short interest is the volume of IN8bio shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 110,200 shares of INAB short. 2.85% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest. What is a good short interest percentage for IN8bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.85% of IN8bio's floating shares are currently sold short. Is IN8bio's short interest increasing or decreasing? IN8bio saw a decline in short interest in July. As of July 31st, there was short interest totaling 110,200 shares, a decline of 23.2% from the previous total of 143,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IN8bio's float size? IN8bio currently has issued a total of 4,540,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 3,860,000 shares. How does IN8bio's short interest compare to its competitors? 2.85% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to IN8bio: Generation Bio Co. (2.15%), Mural Oncology PLC (2.01%), Tempest Therapeutics, Inc. (5.72%), Biodexa Pharmaceuticals PLC Unsponsored ADR (0.49%), NanoViricides, Inc. (0.57%), Tenax Therapeutics, Inc. (9.22%), BioXcel Therapeutics, Inc. (4.84%), FibroBiologics Inc. (3.47%), MIRA Pharmaceuticals, Inc. (3.01%), Natural Alternatives International, Inc. (0.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short IN8bio stock? Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. INAB shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IN8bio? A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further. How often is IN8bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies GBIO Short Interest MURA Short Interest TPST Short Interest BDRX Short Interest NNVC Short Interest TENX Short Interest BTAI Short Interest FBLG Short Interest MIRA Short Interest NAII Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INAB) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access